Filing Flows › Amphastar Pharmaceuticals (AMPH) › Who owns the stock
Who owns Amphastar Pharmaceuticals (AMPH) stock
202 funds reported Amphastar Pharmaceuticals (AMPH) shares in their latest 13F filings, worth $633M in all. The largest holder is BlackRock ($105M). Last quarter 84 funds added to their stakes and 95 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 5,224,934 | $105M | decrease | 2026-06-30 |
| Vanguard Group | 2,608,158 | $69.8M | decrease | 2025-12-31 |
| Dimensional Fund Advisors LP | 2,305,107 | $46.5M | increase | 2026-06-30 |
| State Street | 1,642,126 | $33.1M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 1,481,952 | $29.9M | decrease | 2026-06-30 |
| American Century Companies | 1,176,626 | $23.7M | increase | 2026-06-30 |
| Marshall Wace, LLP | 1,066,322 | $21.5M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 969,840 | $19.6M | decrease | 2026-06-30 |
| Fuller & Thaler Asset Management | 949,238 | $19.2M | decrease | 2026-06-30 |
| D. E. Shaw | 887,048 | $17.9M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 809,568 | $16.3M | increase | 2026-06-30 |
| Mesirow Institutional Investment Management | 380,389 | $14.1M | decrease | 2024-12-31 |
| Renaissance Technologies LLC | 525,100 | $10.6M | decrease | 2026-06-30 |
| Goldman Sachs Group | 505,360 | $10.2M | increase | 2026-06-30 |
| Bridge City Capital, LLC | 383,901 | $9.9M | increase | 2026-09-30 |
Amphastar Pharmaceuticals' latest quarter
Amphastar Pharmaceuticals, Q3 2026: revenue $208M (+8% year over year), operating margin 24.5%, net earnings $37.8M, operating cash flow $43.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most AMPH stock?
By the latest 13F filings: BlackRock ($105M); Vanguard Group ($69.8M); Dimensional Fund Advisors LP ($46.5M); State Street ($33.1M); Vanguard Capital Management LLC ($29.9M).
What is the short interest in AMPH?
4,333,767 shares were sold short at the 2026-10-15 settlement, -1.62% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.